# Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets

> **NCT06193044** · PHASE1 · UNKNOWN · sponsor: **International Bio service** · enrollment: 48 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Amlodipine/Valsartan
- **DRUG:** Amlodipine 10 mg &valsartan 160 mg (Exforge)

## Key facts

- **NCT ID:** NCT06193044
- **Lead sponsor:** International Bio service
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-07
- **Primary completion:** 2024-07-09
- **Final completion:** 2024-07-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06193044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06193044, "Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06193044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*